These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Onychomycosis]. Sato T Med Mycol J; 2016; 57(4):J171-J173. PubMed ID: 27904063 [No Abstract] [Full Text] [Related]
24. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue. Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534 [TBL] [Abstract][Full Text] [Related]
25. PAS is optimal for diagnosing onychomycosis. Barak O; Asarch A; Horn T J Cutan Pathol; 2010 Oct; 37(10):1038-40. PubMed ID: 20412344 [TBL] [Abstract][Full Text] [Related]
26. British Association of Dermatologists' guidelines for the management of onychomycosis 2014. Ameen M; Lear JT; Madan V; Mohd Mustapa MF; Richardson M Br J Dermatol; 2014 Nov; 171(5):937-58. PubMed ID: 25409999 [No Abstract] [Full Text] [Related]
30. [Onychomycosis: recent progress in the epidemiology, diagnosis and treatment]. Hiruma M Nihon Ishinkin Gakkai Zasshi; 2006; 47(2):69-73. PubMed ID: 16699485 [TBL] [Abstract][Full Text] [Related]
31. Comparison of direct smear, culture and histology for the diagnosis of onychomycosis. Karimzadegan-Nia M; Mir-Amin-Mohammadi A; Bouzari N; Firooz A Australas J Dermatol; 2007 Feb; 48(1):18-21. PubMed ID: 17222296 [TBL] [Abstract][Full Text] [Related]
32. Trichophytum rubrum endonyx onychomycosis resistant to standard oral and topical therapies. Mulvaney PM; Telang GH; Jellinek N Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437286 [TBL] [Abstract][Full Text] [Related]
33. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting]. Gerasimchuk EV; Gerasimov VV; Molchanov BA Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907 [No Abstract] [Full Text] [Related]
34. Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution. Bristow I; Baran R; Score M J Drugs Dermatol; 2016 Aug; 15(8):974-8. PubMed ID: 27537998 [TBL] [Abstract][Full Text] [Related]
35. A practical application of onychomycosis cure - combining patient, physician and regulatory body perspectives. Gupta AK; Versteeg SG; Shear NH J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):281-287. PubMed ID: 30005134 [TBL] [Abstract][Full Text] [Related]
36. Topical therapy for toenail onychomycosis: an evidence-based review. Gupta AK; Daigle D; Foley KA Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931 [TBL] [Abstract][Full Text] [Related]
37. Management of toe onychomycosis: what is the potential for improving efficacy of treatment? Gupta AK Clin Dermatol; 2002; 20(5):607-9. PubMed ID: 12435532 [No Abstract] [Full Text] [Related]
38. Efinaconazole and Tavaborole. Poulakos M; Grace Y; Machin JD; Dorval E J Pharm Pract; 2017 Apr; 30(2):245-255. PubMed ID: 26873506 [TBL] [Abstract][Full Text] [Related]
39. Placebo cure rates in the treatment of onychomycosis. Gupta AK; Paquet M J Am Podiatr Med Assoc; 2014 May; 104(3):277-82. PubMed ID: 24901587 [TBL] [Abstract][Full Text] [Related]
40. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study. Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]